Head & Neck Cancers | Specialty

The OncLive Head and Neck Cancer condition center page is a comprehensive resource for clinical news and expert insights on treatment for patients with head and neck cancer. This page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances, and ongoing research within head and neck cancer.

Dr. Cohen Discusses Treating Medullary Thyroid Cancer

July 26th 2012

Dr. Ezra Cohen, from the University of Chicago, Discusses Treating Medullary Thyroid Cancer

Erin McMenamin on Head and Neck Cancer Treatments

June 28th 2012

Erin McMenamin, MSN, Radiation Oncology, Hospital of the University of Pennsylvania, discusses treatments for HPV-positive head and neck cancer, which tends to have a better prognosis than HPV-negative head and neck cancers.

Dr. Kirkman on the Combination of PX-866 and Docetaxel

June 27th 2012

Dr. Robert Kirkman, the CEO of Oncothyreon, on the Combination of PX-866 and Docetaxel

Dr. Cohen Discusses the Cabozantinib EXAM Trial

June 13th 2012

Dr. Ezra Cohen, from the University of Chicago, Discusses the Cabozantinib (XL184) EXAM Trial

Dr. Ladenson on Diagnosis of Thyroid Nodules

May 29th 2012

Dr. Paul W. Ladenson, from Johns Hopkins Medicine, on Diagnosis of Thyroid Nodules

PET/CT Scans Detect Recurrence, But Issues Over Clinical Use Linger

May 29th 2012

The use of PET/CT scans in the detection of early recurrence in patients with squamous cell carcinoma of the head and neck remains an open question, despite recent research suggesting beneficial results.

May 2012: Trials in Progress

May 14th 2012

The Trials in Progress section supplies summaries of ongoing research in a broad range of cancer types.

More Suicides but Fewer Cardiovascular and Pneumonia Deaths Occurring in Patients With Head and Neck Cancer

May 10th 2012

US investigators have found that suicide rates in recent years have significantly increased in patients with oral cavity and oropharyngeal cancer.

Erin McMenamin on HPV-related Head & Neck Cancer

May 6th 2012

Erin McMenamin, MSN, from the Hospital of the University of Pennsylvania, on HPV-related Head & Neck Cancer Prognosis

Oncology Nurses Can Help Mitigate Treatment-Related Side Effects in Head and Neck Cancers

May 5th 2012

Treatment of head and neck cancer often leaves patients with aftereffects that are bothersome at the very least and life-altering at their worst.

Robotic Surgery Is Useful Option for Oral Cancer

April 30th 2012

Minimally invasive transoral robotic surgery, used alone or combined with adjuvant therapy, provides good functional and oncologic outcomes in patients with oropharyngeal squamous cell carcinoma.

Dr. Sherman on Vandetanib's Dosage and Precautions

April 24th 2012

Dr. Eric Sherman, from Memorial Sloan-Kettering Cancer Center, Discusses Vandetanib's Dosage and Precautions

Hypothyroidism Risks With MKIs Examined

April 23rd 2012

A retrospective analysis of the risks of hypothyroidism in patients who received sunitinib and sorafenib is gaining attention in the field of head and neck cancers.

April 2012: Trials in Progress

April 17th 2012

The Trials in Progress section supplies summaries of ongoing research in a broad range of cancer types.

New Indicator May Help Identify Patients With Increased Risk From Throat Cancer

March 19th 2012

Patients with oropharyngeal squamous cell carcinoma who had matted lymph nodes -- nodes that are connected together -- are more likely to metastasize than those without matted lymph nodes.

Oral HPV Infection Affects 7% of the US Population

March 13th 2012

Approximately 7% of Americans are infected with oral human papillomavirus (HPV), and men are 3 times as likely to be infected as women.

Acupuncture Shows Potential for Xerostomia

March 13th 2012

Acupuncture may help prevent xerostomia in patients with nasopharyngeal carcinoma undergoing radiotherapy and may also reduce symptom severity.

HPV Plays Growing Role in Evaluating Therapies

February 16th 2012

Researchers are dissecting new studies regarding targeted therapies as well as combined therapeutic approaches for HPV in the progression of head and neck cancers.

Addition of Bevacizumab May Help in Nasopharyngeal Cancer

February 7th 2012

Researchers are reporting favorable early results with the addition of bevacizumab to conventional chemoradiation in patients with advanced nasopharyngeal cancer.

Dr. Cohen on mTOR Inhibition in Head and Neck Cancer

February 3rd 2012

Dr. Ezra Cohen, from University of Chicago, on mTOR Inhibition in Head and Neck Cancer